Activist investor Bill Ackman is boosting his stake in both Fannie Mae and Freddie Mac to more than 11 percent in each.» Read More
Hedge fund bigwig Paul Tudor Jones trades in some offensive banter; the Fed taper caper continues to obsess the markets; P&G shelves its much-criticized CEO.
Outgoing Procter and Gamble CEO Bob McDonald told employees he will retire due to the "distraction" of all the attention focused on him from "several angles."
A.G. Lafley's return as boss at P&G will be beneficial to the company because he "knows where the bodies are buried," management expert Jeffrey Sonnenfeld tells CNBC.
"Talking Squawk" coming at ya! From your Fed-Chairman-Ben-Bernanke-to-English-Dictionary to the Back-to-the Future move at P&G, this blog is where to get everything "Squawk Box."
Herbalife earnings beat expectations for a 17th straight quarter but its second-quarter outlook fell short.
George Soros disclosed a huge stake in JC Penney, and one big options trader is using the news as a reason to get into the stock.
Herbalife, maker of nutritional and weight loss supplements, said Thursday that two representatives of billionaire investor Carl Icahn will join its board of directors.
Herbalife has already provided one of the best stock market dramas in years. Now, through no fault of its own, it could become a catalyst for change in the auditing profession. The NYT reports.
Ron Johnson's plush taste, against-the-grain ideas and controversial partnership deals all played a hand in his downfall at JC Penney after 17 months. The NYT reports.
George Soros has asked to withdraw hundreds of millions of dollars from Bill Ackman's Pershing Square, according to a WSJ report.
Blogging tidbits, insights, and some sarcasm on the WEEK THAT WAS and the WEEK TO COME from the notepad of the senior executive producer of "Squawk Box."
Carl Icahn boosts his stake in Herbalife to 15.55 percent, according to a regulatory filing.
Bill Ackman/Carl Icahn clash was so mesmerizing that virtually all productivity on Wall Street stopped. Twitter lit up with reactions, and CNBC started trending.
Hedge fund investors Carl Icahn and Bill Ackman slugged it out on CNBC live over Herbalife and other deals. Who won the bout?
Billionaire activist investors Carl Icahn and Bill Ackman trade criticism over Herbalife and beyond.
Bill Ackman says "we will respond to every issue raised by Herblife." CNBC's Herb Greenberg reports.